Twist Bioscience (TWST) Short term Debt (2018 - 2021)

Twist Bioscience has disclosed Short term Debt across 4 years of filings, most recently posting $9.1 million for Q4 2021.

• In Q4 2021, Short term Debt rose 172.49% year-over-year to $9.1 million; the TTM figure through Dec 2021 stood at $9.1 million (up 172.49% YoY), while the FY2021 annual figure was $1.6 million, down 53.44% from the prior year.
• Short term Debt improved to $9.1 million in Q4 2021, from $1.6 million in the prior quarter.
• Over the last five years, Short term Debt for TWST reached as high as $9.1 million in Q4 2021 and fell as low as $1.6 million in Q3 2021.
• The 4-year median for Short term Debt is $3.3 million (2018), against an average of $3.5 million.
• The widest YoY moves for Short term Debt: up 172.49% in 2021, down 53.44% in 2021.
• A 4-year view of Short term Debt shows it stood at $3.3 million in 2018, then changed by 0.0% to $3.3 million in 2019, then changed by 0.0% to $3.3 million in 2020, then jumped by 172.49% to $9.1 million in 2021.
• According to Business Quant data, Short term Debt over the past three periods registered $9.1 million, $1.6 million, and $2.4 million for Q4 2021, Q3 2021, and Q2 2021 respectively.